当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:271.06亿  总市值:271.06亿
流通股本:14.67亿   总股本:14.67亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,196,987,820.314,852,811,188.722,642,116,749.698,601,822,797.73
收到的税费返还183,390,907.225,959,218.114,299,186.44240,406,324.21
收到其他与经营活动有关的现金225,826,912.79178,674,611.9268,038,458.17426,484,363.56
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,606,205,640.35,057,445,018.742,724,454,394.39,268,713,485.5
购买商品、接受劳务支付的现金2,269,316,191.631,405,350,291.73680,766,840.062,248,946,395.86
支付给职工以及为职工支付的现金1,257,345,619.29843,572,887.25462,180,190.031,491,390,001.84
支付的各项税费660,225,730.5479,322,119.35258,595,188.55854,701,437.67
支付其他与经营活动有关的现金1,541,934,311.751,031,372,206.61469,666,132.632,456,654,375.25
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,728,821,853.173,759,617,504.941,871,208,351.277,051,692,210.62
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,877,383,787.131,297,827,513.8853,246,043.032,217,021,274.88
二、投资活动产生的现金流量:
收回投资收到的现金6,030,415.646,030,415.646,030,415.6443,650,177.18
取得投资收益收到的现金428,801.16428,801.16378,914.34,945,053.82
处置固定资产、无形资产和其他长期资产收回的现金净额2,589,148.231,600,006.8188,271.24,843,106.34
收到的其他与投资活动有关的现金---3,233,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计9,048,365.038,059,223.66,597,601.1456,671,337.34
购建固定资产、无形资产和其他长期资产支付的现金1,134,279,640.18788,970,589.8478,288,260.591,592,387,172.07
投资支付的现金60,026,473.7434,500,000-65,582,498.35
支付其他与投资活动有关的现金30,135.18--21,472,575.49
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,194,336,249.1823,470,589.8478,288,260.591,679,442,245.91
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,185,287,884.07-815,411,366.2-471,690,659.45-1,622,770,908.57
三、筹资活动产生的现金流量:
取得借款收到的现金4,012,608,0102,986,057,6001,838,330,0003,310,500,000
收到其他与筹资活动有关的现金---10,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计4,012,608,0102,986,057,6001,838,330,0003,320,500,000
偿还债务支付的现金3,983,809,3002,977,445,100650,387,5003,237,934,094.36
分配股利、利润或偿付利息支付的现金428,305,808.96103,814,180.950,363,358.35568,839,222.75
其中:子公司支付给少数股东的股利、利润11,870,802.511,870,802.5-12,833,300
支付其他与筹资活动有关的现金206,704,634.3201,804,882.0244,547,682.24157,958,706.42
筹资活动现金流出平衡项目0000
筹资活动现金流出小计4,618,819,743.263,283,064,162.92745,298,540.593,964,732,023.53
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-606,211,733.26-297,006,562.921,093,031,459.41-644,232,023.53
四、汇率变动对现金及现金等价物的影响669,731.6943,769,991.6310,975,693.5328,997,894.61
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额86,553,901.49229,179,576.311,485,562,536.52-20,983,762.61
加:期初现金及现金等价物余额1,306,966,362.731,306,966,362.731,306,966,362.731,327,950,125.34
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,393,520,264.221,536,145,939.042,792,528,899.251,306,966,362.73
补充资料:
净利润-754,349,946.71-817,249,345.21
资产减值准备-48,797,615.67-109,244,056.59
固定资产和投资性房地产折旧-382,009,632.69-662,381,858.64
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-382,009,632.69-662,381,858.64
无形资产摊销-56,714,912.31-99,444,623.7
长期待摊费用摊销-6,537,116.88-9,254,640.74
处置固定资产、无形资产和其他长期资产的损失-390,640.63-289,686.98
固定资产报废损失-3,607,305.75-9,988,949.79
公允价值变动损失-67,208,314.63-100,248,243.12
财务费用-70,667,557.63-167,152,416.16
投资损失-14,307,016.13-61,725,476.51
递延所得税--13,470,802.58-12,552,785.97
其中:递延所得税资产减少--13,470,802.58-12,552,785.97
存货的减少-166,007,371.21--140,054,606.58
经营性应收项目的减少--493,303,364.03-269,498,874.84
经营性应付项目的增加-217,474,490.74-19,987,105.43
其他-7,418,886.01--487,734.28
现金的期末余额-1,536,145,939.04-1,306,966,362.73
减:现金的期初余额-1,306,966,362.73-1,327,950,125.34
公告日期2024-10-312024-08-312024-04-302024-04-30
审计意见(境内)标准无保留意见
TOP↑